UK Clinical Pharmacy Association

Acamprosate

Issues for surgery

Risk of alcohol relapse if omitted.

Advice in the perioperative period

Elective and emergency surgery 

Continue.

Post-operative advice

Restart post-operatively as soon as next dose is due.

Monitor renal function – dose reduction may be necessary if renal function is impaired (consult current product literature).

Interactions with common anaesthetic agents

None.

Interactions with other common medicines used in the perioperative period

None.

Further information

None relevant.

References

Baxter K, Preston CL (eds), Stockley’s Drug Interactions (online) London: Pharmaceutical Press. http://www.medicinescomplete.com [Accessed on 4th November 2020]

Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press. http://www.medicinescomplete.com [Accessed on 4th November 2020]

Summary of Product Characteristics – Acamprosate 333mg Gastro-resistant Tablets. Mylan. Accessed via www.medicines.org.uk 04/11/2020 [date of revision of the text June 2020]